Peter D. Senter
53Patents
27h-index
46Co-inventors
88Inventor score
Filing activity: Jul 10, 1984 → Jul 28, 2023
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US4975278A | Antibody-enzyme conjugates in combination with prodrugs for the delivery of cytotoxic agents to tumor cells | Performing Operations; Transporting | 459 | Expired |
| US7498298B2 | Monomethylvaline compounds capable of conjugation to ligands | Emerging Cross-Sectional Technologies | 452 | Expired |
| US6884869B2 | Pentapeptide compounds and uses related thereto | Human Necessities | 278 | Expired |
| US7659241B2 | Drug conjugates and their use for treating cancer, an autoimmune disease or an infectious disease | Chemistry; Metallurgy | 247 | Expired |
| US4569789A | Acid-cleavable compound, use in protein conjugates and drug delivery systems | Chemistry; Metallurgy | 205 | Expired |
| US7745394B2 | Monomethylvaline compounds capable of conjugation to ligands | Emerging Cross-Sectional Technologies | 149 | Active |
| US7964566B2 | Monomethylvaline compounds capable of conjugation to ligands | Emerging Cross-Sectional Technologies | 140 | Active |
| US7091186B2 | p-Amidobenzylethers in drug delivery agents | Human Necessities | 138 | Expired |
| US8697688B2 | Pyrrolobenzodiazepines used to treat proliferative diseases | Chemistry; Metallurgy | 130 | Active |
| US7829531B2 | Drug conjugates and their use for treating cancer, an autoimmune disease or an infectious disease | Chemistry; Metallurgy | 125 | Active |
| US7994135B2 | Monomethylvaline compounds capable of conjugation to ligands | Emerging Cross-Sectional Technologies | 124 | Active |
| US7553816B2 | p-amidobenzylethers in drug delivery agents | Human Necessities | 106 | Expired |
| US4625014A | Cell-delivery agent | Emerging Cross-Sectional Technologies | 103 | Expired |
| US7851437B2 | Drug conjugates and their use for treating cancer, an autoimmune disease or an infectious disease | Chemistry; Metallurgy | 102 | Active |
| US7964567B2 | Monomethylvaline compounds capable of conjugation to ligands | Emerging Cross-Sectional Technologies | 93 | Active |
| US4952394A | Drug-monoclonal antibody conjugates | Human Necessities | 83 | Expired |
| US8609105B2 | Auristatin drug linker conjugates | Emerging Cross-Sectional Technologies | 74 | Active |
| US9242013B2 | Targeted pyrrolobenzodiazapine conjugates | Emerging Cross-Sectional Technologies | 69 | Active |
| US7098308B2 | Pentapeptide compounds and uses related thereto | Human Necessities | 56 | Expired |
| US8703714B2 | Monomethylvaline compounds capable of conjugation to ligands | Emerging Cross-Sectional Technologies | 50 | Active |
| US4542225A | Acid-cleavable compound | Chemistry; Metallurgy | 43 | Expired |
| US4618492A | Acid-cleavable compound | Chemistry; Metallurgy | 43 | Expired |
| US7256257B2 | Pentapeptide compounds and uses related thereto | Human Necessities | 39 | Expired |
| US5773435A | Prodrugs for .beta.-lactamase and uses thereof | Performing Operations; Transporting | 37 | Expired |
| US5041424A | Epipodophyllotoxin glucoside 4'-phosphate derivatives | Human Necessities | 35 | Expired |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.